Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy

per Hashiguchi, Yasunori, Kasai, Mari, Fukuda, Takeshi, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Anticancer Drugs (2015)

UCP2 expression may represent a predictive marker of neoadjuvant chemotherapy effectiveness for locally advanced uterine cervical cancer

per Imai, Kenji, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Oncol Lett (2017)

Metabolic and Morphologic Characteristics of Adipose Tissue Associated with the Growth of Malignant Tumors

per Ishiko, Osamu, Nishimura, Sadako, Yasui, Tomoyo, Sumi, Toshiyuki, Hirai, Kouzo, Honda, Ken‐ichi, Ogita, Sachio
Publicat a Jpn J Cancer Res (1999)

Minimal deviation mucinous adenocarcinoma of the uterine cervix that proved difficult to differentiate from endometrial cancer: A case report

per NISHII, YUKO, FUKUDA, TAKESHI, IMAI, KENJI, YAMAUCHI, MAKOTO, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
Publicat 2014

Sirtuin1 expression predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

per TERAMAE, MASATOMO, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, IMAI, KENJI, YAMAUCHI, MAKOTO, YASUI, TOMOYO, SUMI, TOSHIYUKI
Publicat a Mol Clin Oncol (2015)

Expression of epidermal growth factor-like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

per Yamauchi, Makoto, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Imai, Kenji, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Oncol Lett (2016)

TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma

per Tasaka, Reiko, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Wada, Takuma, Kawanishi, Masaru, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Oncol Lett (2018)

Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma

per Kawanishi, Masaru, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Wada, Takuma, Tasaka, Reiko, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Oncol Lett (2018)

Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors

per NAKANO, YUSUKE, SUMI, TOSHIYUKI, MORISHITA, MASANARI, FUKUDA, TAKESHI, NOBEYAMA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Publicat 2012

Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I–II cervical cancer

per YAMAUCHI, MAKOTO, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, IMAI, KENJI, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
Publicat 2014

Complete recovery from paraneoplastic anti-NMDAR encephalitis associated with a small ovarian teratoma following a laparoscopic salpingo-oophorectomy: A case report

per IMAI, KENJI, FUKUDA, TAKESHI, WADA, TAKUMA, KAWANISHI, MASARU, YAMAUCHI, MAKOTO, HASHIGUCHI, YASUNORI, ICHIMURA, TOMOYUKI, YASUI, TOMOYO, SUMI, TOSHIYUKI
Publicat a Exp Ther Med (2015)

XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

per Wada, Takuma, Fukuda, Takeshi, Shimomura, Masahiro, Inoue, Yuta, Kawanishi, Masaru, Tasaka, Reiko, Yasui, Tomoyo, Ikeda, Kazuo, Sumi, Toshiyuki
Publicat a Oncol Lett (2018)

PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer

per Shimomura, Masahiro, Fukuda, Takeshi, Awazu, Yuichiro, Nanno, Shigenori, Inoue, Yuta, Matsubara, Hiroaki, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Oncol Lett (2021)

PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma

per Matsubara, Hiroaki, Fukuda, Takeshi, Awazu, Yuichiro, Nanno, Shigenori, Shimomura, Masahiro, Inoue, Yuta, Yamauchi, Makoto, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Oncol Lett (2021)

Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

per MORISHITA, MASANARI, SUMI, TOSHIYUKI, NAKANO, YUSUKE, TERAMAE, MASATOMO, FUKUDA, TAKESHI, NOBEYAMA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Publicat 2012

Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma...

per FUKUDA, TAKESHI, SUMI, TOSHIYUKI, TERAMAE, MASATOMO, NAKANO, YUSUKE, MORISHITA, MASANARI, TERADA, HIROYUKI, YOSHIDA, HIROYUKI, MATSUMOTO, YOSHINARI, YASUI, TOMOYO, ISHIKO, OSAMU
Publicat 2013

A retrospective clinical analysis of 5 cases of vaginal melanoma

per Tasaka, Reiko, Fukuda, Takeshi, Wada, Takuma, Kawanishi, Masaru, Imai, Kenji, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Mol Clin Oncol (2017)

Extragastrointestinal stromal tumor originating from the vulva

per Fukuda, Takeshi, Sumi, Toshiyuki, Nakano, Yusuke, Morishita, Masanari, Nobeyama, Hiroyuki, Yoshida, Hiroyuki, Matsumoto, Yoshinari, Yasui, Tomoyo, Honda, Ken-ichi, Ishiko, Osamu
Publicat 2011

Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report

per Wada, Takuma, Fukuda, Takeshi, Kawanishi, Masaru, Tasaka, Reiko, Imai, Kenji, Yamauchi, Makoto, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Biomed Rep (2016)

Age-related differences in prognosis and prognostic factors among patients with epithelial ovarian cancer

per Yoshikawa, Kenji, Fukuda, Takeshi, Uemura, Ryo, Matsubara, Hiroaki, Wada, Takuma, Kawanishi, Masaru, Tasaka, Reiko, Kasai, Mari, Hashiguchi, Yasunori, Ichimura, Tomoyuki, Yasui, Tomoyo, Sumi, Toshiyuki
Publicat a Mol Clin Oncol (2018)